Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
July 31, 2026 12.85%
April 30, 2026 15.32%
January 31, 2026 15.83%
October 31, 2025 14.02%
July 31, 2025 15.19%
April 30, 2025 16.29%
January 31, 2025 17.68%
October 31, 2024 14.12%
July 31, 2024 11.40%
April 30, 2024 14.69%
January 31, 2024 15.05%
October 31, 2023 14.70%
July 31, 2023 13.94%
April 30, 2023 14.77%
January 31, 2023 15.86%
October 31, 2022 13.64%
July 31, 2022 13.06%
April 30, 2022 15.23%
January 31, 2022 16.73%
October 31, 2021 15.11%
July 31, 2021 14.75%
April 30, 2021 16.84%
January 31, 2021 15.68%
October 31, 2020 15.72%
July 31, 2020 13.74%
Date Value
April 30, 2020 15.25%
January 31, 2020 16.36%
October 31, 2019 16.58%
July 31, 2019 15.86%
April 30, 2019 15.89%
January 31, 2019 17.45%
October 31, 2018 16.06%
July 31, 2018 16.44%
April 30, 2018 18.73%
January 31, 2018 18.91%
October 31, 2017 17.10%
July 31, 2017 16.73%
April 30, 2017 18.18%
January 31, 2017 17.97%
October 31, 2016 15.94%
July 31, 2016 15.49%
April 30, 2016 17.10%
January 31, 2016 17.02%
October 31, 2015 16.24%
July 31, 2015 14.99%
April 30, 2015 16.93%
January 31, 2015 15.81%
October 31, 2014 14.88%
July 31, 2014 13.72%
April 30, 2014 15.01%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sundrug Co., Ltd. 25.72%
TSURUHA Holdings, Inc. 30.11%
Sugi Holdings Co., Ltd. 30.84%
COSMOS Pharmaceutical Corp. 20.66%
MatsukiyoCocokara & Co. 35.11%